Deutsche Bank’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$301K Buy
+144,000
New +$283K ﹤0.01% 3032
2020
Q1
– Sell
-1
Closed -$3K – 4685
2019
Q4
$3K Buy
+1
New +$4.99K ﹤0.01% 4771
2018
Q2
– Hold
0
– – – 5555
2018
Q1
– Hold
0
– – – 5545
2017
Q4
– Hold
0
– – – 5092
2017
Q3
– Hold
0
– – – 5025
2017
Q2
– Hold
0
– – – 5063
2017
Q1
– Hold
0
– – – 5057
2016
Q3
– Hold
0
– – – 5122
2016
Q2
– Hold
0
– – – 5300
2016
Q1
– Hold
0
– – – 5292
2015
Q4
– Hold
0
– – – 5373
2015
Q3
– Hold
0
– – – 5006
2015
Q2
– Hold
0
– – – 5040
2015
Q1
– Hold
0
– – – 5704
2014
Q4
– Hold
0
– – – 6270
2014
Q3
– Hold
0
– – – 5507
2014
Q2
– Hold
0
– – – 5574
2014
Q1
– Hold
0
– – – 4511

Other funds holding PALI

Deutsche Bank's PALI Position: Q2 2026 in Review

Deutsche Bank opened a new position in Palisade Bio (PALI) in Q2 2026: 144,000 shares worth $301K. The stake represents ﹤0.01% of the portfolio and ranks #3032 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in PALI as recently as Q4 2019.

Deutsche Bank first reported a position in PALI in Q4 2019 and has held it in 2 quarters since. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Deutsche Bank held 144,000 shares of Palisade Bio worth $301K as of Q2 2026.
  • Palisade Bio was a new Deutsche Bank position in Q2 2026.
  • Palisade Bio made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3032 holding.
  • Deutsche Bank first reported a position in Palisade Bio in Q4 2019 and has held it in 2 quarters since.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.